Announced
Completed
Financials
Sources
Tags
Belgium
molecular diagnostic assays
Private
Acquisition
Majority
Cross Border
Friendly
Medical Services
Single Bidder
Completed
Synopsis
Hologic, a women's health company, completed the acquisition of Diagenode, a European developer and manufacturer of molecular diagnostic assays and epigenetics products, for $159m. “Acquiring Diagenode further strengthens our molecular diagnostics business by expanding our international capabilities, improving our regional time-to-market, and allowing us to offer a broader, more differentiated test menu,” Jan Verstreken, Hologic Group President.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.